Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease

Thorax

Volumn 54, Issue 4, 1999, Pages 367-371

  Polkey, Michael I ^a,c   Lyall, Rebecca A ^a   Davidson, A Craig ^b   Leigh, P Nigel ^b   Moxham, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; OPIATE; PHENOTHIAZINE;

ARTIFICIAL VENTILATION; BREATHING MUSCLE; DYSPNEA; FACE MASK; HEALTH CARE COST; HUMAN; INFERIOR OLIVE; LONGEVITY; MEDICAL ETHICS; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; PALLIATIVE THERAPY; PHYSIOTHERAPY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FUNCTION; REVIEW; RISK; TACHYPNEA; TRACHEOSTOMY;

EID: 0033025345     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.4.367     Document Type: Review

References (43)

1. 1 Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-19.
2. 2 Chen R, Grand'Maison F, Strong MJ, et al. Motor neuron disease presenting as acute respiratory failure: a clinical and pathological study. J Neurol Neurosurg Psychiatry 1996;60: 455-8.
3. 3 Sivak E, Gipson T, Hanson M. Long term management of respiratory failure in amyotrophic lateral sclerosis. Ann Neurol 982;12:18-23.
4. 4 Schiffman PL, Belsh JM. Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration. Chest 1993;103:508-13.
5. 5 Polkey MI, Lyall RA, Green M, et al. Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998;158:734-41.
6. 6 Nakano K, Bass H, Tyler HR, et al. Amyotrophic lateral sclerosis: a study of pulmonary function. Dis Nerv Syst 1976;37:32-4.
7. 7 Ferguson KA, Strong MJ, Ahmad D, et al. Sleep disordered breathing in amyotrophic lateral sclerosis. Chest 1996;110: 664-9.
8. 8 Sanjak M, Paulson D, Sufit R, et al. Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology 1987;37:1217-20.
9. 9 Mier-Jedrzejowicz A, Brophy C, Moxham J, et al. Assessment of diaphragm weakness. Am Rev Respir Dis 1988;137: 877-83.
10. 10 Polkey MI, Green M, Moxham J. Measurement of respiratory muscle strength. Thorax 1995;50:1131-5.
11. 11 Bach JR. Update and perspective on noninvasive respiratory muscle aids. Part 2: Expiratory aids. Chest 1994;105:1538-44.
12. 12 Gay PC, Edmonds LC. Severe hypercapnia after low-flow oxygen therapy in patients with neuromuscular disease and diaphragmatic dysfunction. Mayo Clin Proc 1995;70:327-30.
13. 13 O'Brien T, Kelly M, Saunders C. Motor neurone disease: a hospice perspective. BMJ 1992;304:471-3.
14. 14 Hayashi H, Kato S, Kawada A. Amyotrophic lateral sclerosis patients living beyond respiratory failure. J Neurol Sci 1991;105:73-8.
15. 15 Oppenheimer E. Decision-making in the respiratory care of amyotrophic lateral sclerosis: should home mechanical ventilation be used? Palliative Med 1993;7(Suppl 2):49-64.
16. 16 Jackson M, Kinnear W, King M, et al. The effects of five years of nocturnal cuirass-assisted ventilation in chest wall disease. Eur Respir J 1993;6:630-5.
17. 17 Chalmers RM, Howard RS, Wiles CM, et al. Use of the rocking bed in the treatment of neurogenic respiratory insufficiency. Q J Med 1994;87:423-9.
18. 18 Howard RS, Wiles CM, Loh L. Respiratory complications and their management in motor neuron disease. Brain 1989;112:1155-70.
19. 19 Sawicka EH, Loh L, Branthwaite MA. Domiciliary ventilatory support: an analysis of outcome. Thorax 1988;43:31-5.
20. 20 Ellis ER, Bye PT, Bruderer JW, et al. Treatment of respiratory failure during sleep in patients with neuromuscular disease. Positive-pressure ventilation through a nose mask. Am Rev Respir Dis 1987;135:148-52.
21. 21 Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute respiratory failure due to chronic obstructive airways disease. Lancet 1993;341: 1555-7.
22. 22 Lyall RA, Green M, Leigh PN, et al. Maximal sniff nasal pressure in the assessment of patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998;157:A360.
23. 23 Davison A, Mulvey D. Idiopathic diaphragmatic weakness. BMJ 1992;304:492-4.
24. 24 Raphael J-C, Chevret S, Chastang C, et al for the French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. Lancet 1994;343:1600-4.
25. 25 Cazzolli P, Oppenheimer EA. Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation. J Neurol Sci 1996;139(Suppl):123-8.
26. 26 Bach JR. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. Arch Phys Med Rehabil 1995;76:828-32.
27. 27 Bach JR, Alba AS. Intermittent abdominal pressure ventilator in a regimen of noninvasive ventilatory support. Chest 1991;99:630-6.
28. 28 Pinto AC, Evangelista T, Carvalho M, et al. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ ALS patients: survival rates in a controlled trial. J Neurol Sci 1995;129:19-26.
29. 29 Moss A, Casey P, Stocking C, et al. Home ventilation for amyotrophic lateral sclerosis patients. Neurology 1993;43: 438-43.
30. 30 McDonald ER, Hillel A, Wiedenfield SA. Evaluation of the psychological status of ventilatory supported patients with ALS/MND. Palliative Med 1996;10:35-41.
31. 31 Moss A, Oppenheimer EA, Casey P, et al. Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation. Chest 1996;110:249-55.
32. 32 Vick SD. Caring for ventilated patients in the community: a pilot study examining costs, quality of life and preferences. Health Soc Care Comm 1996;4:330-7.
33. 33 Garcia-Pachon E, Marti J, Mayos M, et al. Clinical significnce of upper airway dysfunction in motor neurone disease. Thorax 1994;49:896-900.
34. 34 Robbins J, Scanlan K, Brooks BR. Recumbent apnea in amyotrophic lateral sclerosis (ALS) caused by mesopharyngeal closure due to epiglottic obstruction. Neurology 1988;38(Suppl 1):425.
35. 35 Aboussouan LS, Khan SU, Meeker DP, et al. Effect of non-invasive positive pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997;127: 450-3.
36. 36 Lacomblez L, Bensimon G, Leigh PN, et al. Dose ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996;347:1425-31.
37. 37 Brooks BR, for the World Federation of Neurology Research Group on Neuromuscular Diseases. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(Suppl):96-107.
38. 38 Szeinberg A, Tabachnik E, Rashed N, et al. Cough capacity in patients with muscular dystrophy. Chest 1988;94:1232-5.
39. 39 Goldblatt D, Greenlaw J. Starting and stopping the ventilator for patients with amyotrophic lateral sclerosis. Neurol Clin 1989;7:789-806.
40. 40 Make BJ, Hill NS, Goldberg AI, et al. Mechanical ventilation beyond the intensive care unit. Report of a Consensus Conference of the American College of Chest Physicians. Chest 1998;113:289-343s.
41. 41 Brody H, Campbell ML, Faber-Langendoen K, et al. Withdrawing intensive life sustaining treatment: recommendations for compassionate clinical management. N Engl J Med 1997;336:652-7.
42. 42 American Thoracic Society. Withdrawing and withholding life-sustaining therapy. Ann Intern Med 1991;115:478-85.
43. 43 Simonds AK. Non-invasive respiratory support. London: Chapman and Hall, 1996.